HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain
Cardio 2022

Saule Urazalina

Saule Urazalina, Speaker at Cardiovascular Conference
Asfendiarov Kazakh National Medical University, Kazakhstan
Title : Correlation of arterial stiffness parameters with indicators of carotid atherosclerosis in patients with Metabolic Syndrome


A number of studies have shown that metabolic syndrome (MetS) is accompanied by an increase in arterial stiffness. In connection therewith, early detection of an increase in arterial stiffness in patients with MetS can help to prevent cardiovascular complications of them. Aim. To determine the relationship between arterial stiffness parameters such as cfPWV and CAVI with carotid atherosclerosis indicators (IMT, carotid plaque presence) in patients with metabolic syndrome. Methods. The study included 100 patients at the age of 40-70 years: 45 men and 55 women (56.54 ± 8.98 y.) Subjects were divided into 2 groups: 1st - 42 patients with MetS; 2nd - 58 patients without MetS. The arterial stiffness parameters such as CAVI and cfPWV were calculated. In analysis we used threshold values recommended by manufacturers and European expert consensus document on arterial stiffness: for CAVI – 0.05). In the group without MetS none of the arterial stiffness parameters (CAVI, cfPWV) did not statistically significantly correlated with any of the carotid atherosclerosis indicators (p>0.05). Conclusion. The CAVI parameter, in contrast to the cfPWV, was statistically significantly correlated with indicators of carotid atherosclerosis in patients with metabolic syndrome. In this connection, this parameter can be used to identify signs of not only increased arterial stiffness, but also to determine subclinical signs of carotid atherosclerosis in patients with metabolic syndrome. Key words: metabolic syndrome, arterial stiffness, CAVI, carotid atherosclerosis

What will audience learn from your presentation?
Explain how the audience will be able to use what they learn?
-The audience can use the results of this work in their future research
? How will this help the audience in their job? -CAVI parameter can be used to identify subclinical signs of carotid atherosclerosis  Is this research that other faculty could use to expand their research or teaching?
-Yes, our research could be used by other faculty to expand their research.
Does this provide a practical solution to a problem that could simplify or make a designer’s job more efficient?
-We think that results of our research may give some practical solution to the problem of atherosclerotic early signs diagnostics in patients with metabolic syndrome.
Will it improve the accuracy of a design, or provide new information to assist in a design problem?
We find it difficult to answer this question


Professor Saule Urazalina graduated as medical doctor from the 1-st Moscow medical Institute, Russia, in 1987. She worked in the research group of Prof. Boytsov S.A. at the Russian Cardiology Research-andProduction Center, Ministry of Health, Russia, Moscow from 2009 to 2013y.y. After defending her doctoral dissertation, she received the degree of Medical doctor Sciences and PhD degree at the same organization. Now she works as a professor of the cardiology department of NPJS «Asfendiarov Kazakh National Medical University», Almaty, Kazakhstan. She has published more than 50 research articles in medical science journals, including journals reviewed by Scopus.